Volume 71, Number 14, September 30, 2008
About this course
- Released: 09/29/2008
- Expires: 09/30/2010
Learning Objectives:
Upon completion of the article by Rönnemaa et al., the participant should be able to state:
• The risk factors for Alzheimer disease (AD) identified at age 50, for the ensuing 32 years
• The risk factors shown for AD in patients with an APOE
4 allele• The form of dementia that has a significant association with glucose tolerance and insulin resistance
Core Competencies:
The article by Rönnemaa et al. covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Fischer et al., the participant should be able to:
• State the polymerase chain reaction (PCR) detection rate for meningeal spread of primary central nervous system lymphoma (PCNSL) when the cytomorphology test is negative or positive
• Discuss the authors' recommendations about the use of cytomorphologic testing verus IgH PCR for the detection of meningeal spread in patients with PCNSL
Core Competencies:
The article by Fischer et al. covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
